Showing results (131-140 of 256) with videos related to

Sort By:
Pageof 26
Nederlands Tijdschrift Voor Geneeskunde|August 22, 2008
[The formation of infliximab and anti-infliximab immune complexes as an explanation for non-responding to infliximab treatment of rheumatoid arthritis: observational study in 4 patients]C J van der Laken, A E Voskuyl, J C Roos, et al.
Annals of the Rheumatic Diseases|May 1, 2009
Ankylosing spondylitis: a risk factor for myocardial infarction?M J L Peters, I Visman, M M J Nielen, et al.
Annals of the Rheumatic Diseases|July 24, 2008
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissueA W R van Kuijk, D M Gerlag, K Vos, et al.
Annals of the Rheumatic Diseases|November 18, 2004
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral densityM C Lodder, Z de Jong, P J Kostense, et al.
Annals of the Rheumatic Diseases|August 17, 2004
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled studyT K Kvien, J S H Gaston, T Bardin, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formationMirjam K de Vries, Gerrit Jan Wolbink, Steven O Stapel, et al.
Annals of the Rheumatic Diseases|December 24, 2008
The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional studyH G Raterman, I C van Eijk, A E Voskuyl, et al.
Annals of the Rheumatic Diseases|April 12, 2006
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritisM Vis, E A Havaardsholm, G Haugeberg, et al.
JAMA|April 14, 2011
Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-upGeertje M Bartelds, Charlotte L M Krieckaert, Michael T Nurmohamed, et al.
The Journal of Rheumatology|September 12, 2008
Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritisWouter H Bos, Geertje M Bartelds, Gerrit Jan Wolbink, et al.
Pageof 26